Delivery Order SPE2DB24D2205-SPE2DB25FDSTK

Award Date 10/16/24
Potential Completion Date 10/17/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,559,459 units of Depakote DR 125 mg sprinkle capsules. The $2,097.41 firm fixed-price contract was awarded on December 27, 2022 by the Defense Logistics Agency (DLA), with a completion date of December 28, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This federal contract award, valued at $1,064.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Depakote DR 125 mg sprinkle capsules, a medication used for various neurological and psychiatric conditions. The contract has an ultimate completion date of August 10, 2022 and is a Firm Fixed Price (FFP) agreement. The award is not associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Depakote DR 125 mg sprinkle capsules. The Delivery Order, valued at $1,350.72, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of pharmaceutical products, including Depakote DR 250 mg tablets, to the Defense Logistics Agency (DLA). The $1,154.25 delivery order is a firm fixed-price contract with a completion date of June 5, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the...
This federal contract award is for the delivery of 4,559,180 units of the pharmaceutical product Depakote DR 125 mg sprinkle capsules. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $2,774.15 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $1,067.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. for the delivery of 4,565,232 units of Depakote DR 125 mg Sprinkle capsules. The contract has a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,526.43 firm fixed-price contract is for the delivery of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a medication used for the treatment of various conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,090.64, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, worth up to $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery...
This federal contract award is for the delivery of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract, valued at $2,524.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 21, 2021 with a completion date of December 22, 2021. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSTK
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $2,489.13 for the supply of 4,566,120,598 units of Depakote DR 125 mg sprinkle capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024.

AmerisourceBergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively. These IDCs serve as primary vehicles for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, law enforcement, and other federal beneficiaries. The contract award reviewed is not designated with a set-aside requirement, indicating open competition.

Generated 1/15/25, 9:30 AM